<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210308050636N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-06-14</date_registration>
      <primary_sponsor>Gorgan University of Medical Sciences</primary_sponsor>
      <public_title>Detrmining the effect of applying pain management protocol on nurses' clinical performance</public_title>
      <acronym></acronym>
      <scientific_title>Studying the effectiveness of applying neonatal pain management protocol  on nurses' clinical performance</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-12-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>50</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/56376</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Health service research, Other design features: These study is a stepped-wedge randomized cluster trial. The three hospitals will be included in the study in the form of three clusters. First, the clusters enter the basic evaluation stage. After collecting information through observation and a protocol-based checklist, the first cluster is randomly allocated to the intervention arm. The research team will teach the content and the manner of using the protocol (using workshop and  installing educational posters in the ward) to all nurses working in the neonatal units of interested center. After completing the training program, the protocol  will be implemented in neonatal wards of the center and the head nurses will act as mentors to guide the nurses during the implementation of the protocol. While implementing the protocol  in the the first center, two other centers will be considered as control centers. They will continue using the routine manner of pain management for the hospitalized neonates. After two weeks, the data related to the quality of nurses’ performance in neonatal pain management  and the severity of neonatal procedural pain will be collected simultaneously in all three centers. After accomplishing the data gathering, the intervention will be done for the second center and the third center as a control center, will continue using the routine manner of pain management for the hospitalized neonates. After two weeks, the data related to the quality of nurses’ performance and the severity of neonatal procedural pain will be collected simultaneously in all two centers. The third center also get the intervention after the completion of the effectiveness evaluation phase, because of ethical issues. After all, the Primary and secondary outcomes, i.e., nurses’ performance in the management of neonatal pain and severity on neonatel pain during painful procedures, will be evaluated using a nurses performance checklist (developed based on the protocol) and Profile-Revised (PIPP-R) Premature Infant Pain for 4 months with 2-month intervals to determine the sustenability of practice change in neonatal pain management, Randomization description: In the study interesed centers (n=3) will be allocated randomly. Since all centers will enter the study in a stepwise manner, we will use the random method to determine the order in which they allocate into the intervention arm. Thus, different modes of centers entrance (six modes: 1-2-3 / 1-3-2 / 2-1-2 / 3-3-3 / 1-1-2- / 3-2-1) will be written on the seprate cards  and placed inside the sealed envelope. Then one of the envelopes will be selected randomly (a random number between 1 to 6). All eligible nurses will enter the study, Blinding description: Observing and recording the nurses' performance and neonates'pain severity will be done by evaluators who are not aware of the purpose of the study.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Pain management in neonates.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: the neonatal pain management protocol includes evidence-based recommendations on pain prevention, assessment, pain relief interventions, and documentation. The assessment step describes diagnosing the cause and severity of neonates’ pain using appropriate tools and interpreting the scores. The pain relief interventions include pharmacological methods such as prescribed drugs (painkillers and EMLA Cream, etc.) and/or non-pharmacological methods such as breast milk, sucrose, non-nutritional sucking, KMC, etc. At first, the above mentioned protocol will be developed based on the John Hopkins Nursing Evidence-Based Practice Model and then, after training the nurses working in interested wards about the content and applying method of the protocol the implementation phase of the protocol as an intervention will begin. Intervention 2: Control group: routine care.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Homeira Khoddam</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Nursing and Midwifery, Falsafi Educational Campus, Golestanuniversity of Medical Science, Shast Kola Road, Hircan blvd.</address>
        <city>Gorgan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4934174515</zip>
        <telephone>+98 911 371 5485</telephone>
        <email>khoddam@goums.ac.ir</email>
        <affiliation>Gorgan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Homeira Khoddam</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Nursing and Midwifery, Falsafi Educational Campus, Golestanuniversity of Medical Science, Shast Kola Road, Hircan blvd.</address>
        <city>Gorgan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4934174515</zip>
        <telephone>+98 17 3245 6900</telephone>
        <email>khoddam@goums.ac.ir</email>
        <affiliation>Gorgan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Nurses working in the neonatal wards and NICUs of the study hospitals
MSc degree or higher in Nursing
Admitted Neonates in in the neonatal wards and NICUs of the study hospitals
Neonates with gestational age 34 week and more</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Having the position of head nurse in the study wards</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: the neonatal pain management protocol includes evidence-based recommendations on pain prevention, assessment, pain relief interventions, and documentation. The assessment step describes diagnosing the cause and severity of neonates’ pain using appropriate tools and interpreting the scores. The pain relief interventions include pharmacological methods such as prescribed drugs (painkillers and EMLA Cream, etc.) and/or non-pharmacological methods such as breast milk, sucrose, non-nutritional sucking, KMC, etc. At first, the above mentioned protocol will be developed based on the John Hopkins Nursing Evidence-Based Practice Model and then, after training the nurses working in interested wards about the content and applying method of the protocol the implementation phase of the protocol as an intervention will begin.</i_keyword>
      <i_keyword>Control group: routine care</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Quality of nurses’ performance in neonatal pain management. Timepoint: At baseline, 7, 10,18, 26 weeks after start of basic data collection. Method of measurement: The designed checklist  based on the neonatal pain management protocol.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Severity on neonatal pain during painful procedures. Timepoint: At baseline, 7, 10,18, 26 weeks after start of basic data collection. Method of measurement: Profile-Revised (PIPP-R) Premature Infant Pain.</sec_outcome>
      <sec_outcome>Nurses' adherence to the use of evidence-based protocol and changes in the neonatal pain management process in the relevant wards. Timepoint: At baseline, 7, 10,18, 26 weeks after start of basic data collection. Method of measurement: The designed checklist  based on neonatal pain management protocol.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Gorgan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-05-23</approval_date>
        <contact_name>Ethics committee of Golestan University of Medical Sciences</contact_name>
        <contact_address>Research and Technology Deputy, Golestan University of Medical Sciences Gorgan Golestan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
